Journal Publications

Author Gurwith M, Condit RC, Excler JL, Robertson JS, Kim D, Fast PE, Drew S, Wood D, Klug B, Whelan M, Mallett Moore T, Khuri-Bulos N, Smith ER, Chen RT, Kochhar S
Title Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
Journal Name Vaccine
Month / Year 01/2021
Vol (No) 38 (49)
Page 7702 ~ 7
Link
Abstract

Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of live-attenuated viral vaccines. This will help key stakeholders assess potential safety issues and understand the benefit-risk of such vaccines. The standardized and structured assessment provided by the template would also help to contribute to improved communication and support public acceptance of licensed live-attenuated viral vaccines.

Keyword COVID-19 Vaccines/adverse effects/pharmacology; Drug Evaluation, Preclinical/methods/*standards; Humans; Risk Assessment; Societies, Scientific; Vaccines, Attenuated/*adverse effects/pharmacology; Viral Vaccines/*adverse effects/pharmacology
DONATE